Meeting Banner
Abstract #3380

Quantitative DCE-MRI Assessment of Breast Cancer Therapeutic Response: How Long Is the Acquisition Time Necessary?

Mohan L. Jayatilake1, Xin Li1, Alina Tudorica1, Karen Oh1, Nicole Roy1, Stephen Chui1, Wei Huang1

1Oregon Health & Science University, Portland, OR, United States

Breast cancer patients underwent DCE-MRI studies before, after first cycle, at midpoint, and after completion of neoadjuvant chemotherapy. Ktrans and kep after first therapy cycle and their % changes (relative to baseline) provide early discrimination of pathologic complete responders (pCRs) from non-pCRs. Representative 10-min long DCE-MRI data from one pCR and one non-pCR were reprocessed with simulated acquisition time as short as ~ 3 min. It was found that DCE-MRI acquisition time of 5-6 min is sufficient for the purpose of early prediction of therapy response. Shorter DCE-MRI protocol reduces patient discomfort and minimizes motion artifacts.

Keywords

accounts achieve acquisition acquisitions actually advanced agent albeit amount analyses artificially assessment better beyond bilateral biopsy blue breast cancer characteristic chemotherapy clear column commonly complete completion consented contrast course coverage covering curve cycle cycles definitive demonstrating derive derived described determine diminished discomfort discriminate discriminating discrimination discriminatory dominant drawn dropped early either eleven enhanced enhances entire evaluating even exchange expected experienced extract features fitting full gadolinium generated good gradient graphs greater health indicates injection intensity kinetics locally long maps matrix metrics midpoint model motion nearly necessary often pathologic patient patients pixel predicting prediction presumably previously probably protocol quality quantitative quite radiologists radiology recent reduce reduced relatively remain respectively responder responders response revealed review robust sacrificing saturation scale scanner science selected short shortening shorter significantly simulated simulating simulation specimens speed stable still studies subjected substantially sufficient support system temporal therapeutic therapy tumor tumors uncertainty undergoing underwent unnecessary usually varying vertical volume whole zero